Last reviewed · How we verify
NCT05988827: EMERGING
Effect of Minimizing Light Exposure Intensity on Macular Function After Cataract Surgery in Patients With Early or Intermediate AMD
NA trial testing NGenuity in Macular Degeneration, Age Related in 42 participants. Completed in 9 August 2024.
10 July 2024
Quick facts
| Lead sponsor | Elsan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 42 |
| Start date | 14 September 2023 |
| Primary completion | 10 July 2024 |
| Estimated completion | 9 August 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- NGenuity
Conditions studied
- Macular Degeneration, Age Related — all drugs for Macular Degeneration, Age Related →
- Cataract — all drugs for Cataract →
Sponsor
Elsan — full company profile →
Who can join
18 and older, any sex, with Macular Degeneration, Age Related or Cataract. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cataract surgery is one of the most frequently performed surgical interventions worldwide. The microscope light-induced retinal toxicity after cataract surgery has been described in several reports even in short procedures; however, this potential toxicity has not been evaluated by objective criteria. Indeed, this retinal phototoxicity would be increased for patients with mild macular diseases such as early stages of AMD (Aged Macular Degeneration) (ie: drusen) which are frequently associated in elderly patients with cataract. The aim of the study will be to assess the potential functional macular effects by focal and multifocal ERG after cataract surgery with NGenuity by comparison to Standard Operating Microscope (SOM). This study would particularly address eyes at risk for macular toxicity like patients with early or intermediate AMD
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05988827
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Macular Degeneration, Age Related
Currently open trials in the same condition.
- NCT06582511 — Evaluating Metabolic Changes Induced by PhotoBioModulation Through Spectrally Resolved Autofluorescence in Dry Age-Relat · active not recruiting
Other Elsan trials
Trials by the same sponsor.
- NCT07464665 — Comparing Dual-mobility Cups Versus Unipolar Cups for Unselected Primary Total Hip Arthroplasty by Direct Anterior Appro · NA · not yet recruiting
- NCT07267572 — Evaluation of the Added Value of Logotherapy in the Psychological Support of Patients With Primary Breast Cancer · NA · not yet recruiting
- NCT07248124 — Pilot Study, Aimed at Describing in Myography, the Collapse of the Muscular Response Visualized in the Scratch Collapse · NA · recruiting
- NCT06835790 — Comparative 3-year Study of Nissen-sleeve vs. Sleeve Plus Cruroplasty in Obese Patients With Hiatal Hernia · NA · not yet recruiting
- NCT06822452 — Prospective Comparative Study Evaluating the Early Complications of Robot-assisted Radical Prostatectomy Performed as an · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05988827 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Elsan
- Last refreshed: 3 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05988827.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing